These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 33163283)

  • 1. Inhibition of AURKB, regulated by pseudogene
    Guo Y; Wei Q; Tan L; Li Y; Li J; Li L; Jiang T; Zhang S; Jin H
    Am J Cancer Res; 2020; 10(10):3458-3474. PubMed ID: 33163283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zebrafish modeling reveals that SPINT1 regulates the aggressiveness of skin cutaneous melanoma and its crosstalk with tumor immune microenvironment.
    Gómez-Abenza E; Ibáñez-Molero S; García-Moreno D; Fuentes I; Zon LI; Mione MC; Cayuela ML; Gabellini C; Mulero V
    J Exp Clin Cancer Res; 2019 Sep; 38(1):405. PubMed ID: 31519199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PSMC2 knockdown suppressed tumor progression of skin cutaneous melanoma.
    Yang Y; Qi F; Wei C; Liu J; Zhang Y; Luan W; Gu J
    Cell Death Discov; 2021 Oct; 7(1):323. PubMed ID: 34716318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aurora kinase targeting in lung cancer reduces KRAS-induced transformation.
    Dos Santos EO; Carneiro-Lobo TC; Aoki MN; Levantini E; Bassères DS
    Mol Cancer; 2016 Feb; 15():12. PubMed ID: 26842935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of B cells in cutaneous melanoma.
    Selitsky SR; Mose LE; Smith CC; Chai S; Hoadley KA; Dittmer DP; Moschos SJ; Parker JS; Vincent BG
    Genome Med; 2019 May; 11(1):36. PubMed ID: 31138334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudogenes transcribed in breast invasive carcinoma show subtype-specific expression and ceRNA potential.
    Welch JD; Baran-Gale J; Perou CM; Sethupathy P; Prins JF
    BMC Genomics; 2015 Feb; 16(1):113. PubMed ID: 25765044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic implication and functional annotations of APOBEC3G expression in patients with Melanoma.
    Han W; Xu J; Shen GL
    J Cancer; 2020; 11(17):5245-5256. PubMed ID: 32742470
    [No Abstract]   [Full Text] [Related]  

  • 8. SKA3 overexpression predicts poor outcomes in skin cutaneous melanoma patients.
    Pang H; Zhou Y; Wang J; Wu H; Cui C; Xiao Z
    Transl Oncol; 2022 Jan; 15(1):101253. PubMed ID: 34737118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Observed Survival Interval: A Supplement to TCGA Pan-Cancer Clinical Data Resource.
    Xiong J; Bing Z; Guo S
    Cancers (Basel); 2019 Feb; 11(3):. PubMed ID: 30813652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of CD38 as a potential biomarker in skin cutaneous melanoma using bioinformatics analysis.
    Wang X; Wang P; Ge L; Wang J; Naqvi SMAS; Hu S
    Oncol Lett; 2020 Oct; 20(4):12. PubMed ID: 32774485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct prognostic value of mRNA expression of guanylate-binding protein genes in skin cutaneous melanoma.
    Wang Q; Wang X; Liang Q; Wang S; Xiwen L; Pan F; Chen H; Li D
    Oncol Lett; 2018 May; 15(5):7914-7922. PubMed ID: 29725478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymidine Kinase 1 Drives Skin Cutaneous Melanoma Malignant Progression and Metabolic Reprogramming.
    Zuo S; Wang H; Li L; Pan H; Lu L
    Front Oncol; 2022; 12():802807. PubMed ID: 35311151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic Analysis of the Prognosis-Related RNA Alternative Splicing Signals in Melanoma.
    Xue D; Cheng P; Jiang J; Ren Y; Wu D; Chen W
    Med Sci Monit; 2020 Mar; 26():e921133. PubMed ID: 32199022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting Aurora kinase B attenuates chemoresistance in glioblastoma via a synergistic manner with temozolomide.
    Alafate W; Wang M; Zuo J; Wu W; Sun L; Liu C; Xie W; Wang J
    Pathol Res Pract; 2019 Nov; 215(11):152617. PubMed ID: 31563286
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Lu JJ; Chen FJ; Li Y; Xu X; Peng C; Yu N; Su LN; Tang L
    Ann Transl Med; 2022 Jan; 10(2):68. PubMed ID: 35282044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MGMT inhibition in ER positive breast cancer leads to CDC2, TOP2A, AURKB, CDC20, KIF20A, Cyclin A2, Cyclin B2, Cyclin D1, ERα and Survivin inhibition and enhances response to temozolomide.
    Bobustuc GC; Kassam AB; Rovin RA; Jeudy S; Smith JS; Isley B; Singh M; Paranjpe A; Srivenugopal KS; Konduri SD
    Oncotarget; 2018 Jul; 9(51):29727-29742. PubMed ID: 30038716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic value of the proteasome activator subunit gene family in skin cutaneous melanoma.
    Wang Q; Pan F; Li S; Huang R; Wang X; Wang S; Liao X; Li D; Zhang L
    J Cancer; 2019; 10(10):2205-2219. PubMed ID: 31258724
    [No Abstract]   [Full Text] [Related]  

  • 18. MicroRNA-365 Inhibits Cell Growth and Promotes Apoptosis in Melanoma by Targeting BCL2 and Cyclin D1 (CCND1).
    Zhu Y; Wen X; Zhao P
    Med Sci Monit; 2018 Jun; 24():3679-3692. PubMed ID: 29858490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-proliferative and pro-apoptotic effects of curcumin on skin cutaneous melanoma: Bioinformatics analysis and
    Li L; Lu S; Ma C
    Front Genet; 2022; 13():983943. PubMed ID: 36171883
    [No Abstract]   [Full Text] [Related]  

  • 20. Cancer systems biology of TCGA SKCM: efficient detection of genomic drivers in melanoma.
    Guan J; Gupta R; Filipp FV
    Sci Rep; 2015 Jan; 5():7857. PubMed ID: 25600636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.